Citadel Advisors’s enVVeno Medical NVNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$130K Buy
+15,314
New +$160K ﹤0.01% 12701
2026
Q1
– Sell
-1,221
Closed -$13.7K – 13830
2025
Q4
$13.7K Sell
1,221
-345
-22% -$6.7K ﹤0.01% 12406
2025
Q3
$49.7K Buy
1,566
+735
+88% +$75.1K ﹤0.01% 12217
2025
Q2
$116K Buy
831
+76
+10% +$8.98K ﹤0.01% 11203
2025
Q1
$69.5K Sell
755
-2,283
-75% -$254K ﹤0.01% 11920
2024
Q4
$321K Buy
3,038
+3,009
+10,376% +$336K ﹤0.01% 9519
2024
Q3
$3.38K Sell
29
-175
-86% -$32.2K ﹤0.01% 13662
2024
Q2
$37.5K Sell
204
-1,098
-84% -$192K ﹤0.01% 12046
2024
Q1
$248K Buy
1,302
+161
+14% +$28.9K ﹤0.01% 9881
2023
Q4
$205K Buy
+1,141
New +$182K ﹤0.01% 9897
2023
Q3
– Sell
-1,288
Closed -$139K – 14832
2023
Q2
$139K Buy
+1,288
New +$167K ﹤0.01% 10442
2023
Q1
– Sell
-317
Closed -$56.5K – 15251
2022
Q4
$56.5K Sell
317
-254
-44% -$51.6K ﹤0.01% 11974
2022
Q3
$126K Buy
+571
New +$122K ﹤0.01% 10885
2021
Q2
– Sell
-329
Closed -$77K – 14173
2021
Q1
$77K Buy
+329
New +$91.6K ﹤0.01% 12667
2020
Q4
– Sell
-147
Closed -$56K – 11328
2020
Q3
$56K Buy
+147
New +$49.8K ﹤0.01% 9561
2019
Q1
– Sell
-16
Closed -$20K – 9685
2018
Q4
$20K Buy
+16
New +$28.8K ﹤0.01% 8755

Other funds holding NVNO

Citadel Advisors's NVNO Position: Q3 2026 in Review

Citadel Advisors opened a new position in enVVeno Medical (NVNO) in Q3 2026: 15,314 shares worth $130K. The stake represents ﹤0.01% of the portfolio and ranks #12701 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NVNO as recently as Q4 2025.

Citadel Advisors first reported a position in NVNO in Q4 2018 and has held it in 16 quarters since. The position peaked at $321K in Q4 2024. 17 funds tracked by Wall St. Rank hold NVNO as of Q3 2026.

  • Citadel Advisors held 15,314 shares of enVVeno Medical worth $130K as of Q3 2026.
  • enVVeno Medical was a new Citadel Advisors position in Q3 2026.
  • enVVeno Medical made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #12701 holding.
  • Citadel Advisors first reported a position in enVVeno Medical in Q4 2018 and has held it in 16 quarters since.
  • Citadel Advisors's enVVeno Medical position peaked at $321K in Q4 2024.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.